High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.-Reference-Cited by-同舟云学术

High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.

Published:1985-03-23 Issue:6472 Volume:290 Page:889-893
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Lambert H E,Berry R J

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference23 articles.

1. Chemotherapy of ovarian cancer past and present;Young, R.C.;Semin Oncol,1975

2. Improved therapy with cisplatinum regimens for patients with ovarian carcinoma (FIGO stages III and IV) as measured by surgical end-staging (second look operation);Cohen, C.J.; Goldberg, J.D.; Holland, J.F.;Am -7 Obstet Gynecol

3. cyclophosphamide (PAC) vs hexamethylmelamine, Adriamycin and cyclophosphamide (HAC) an advanced ovarian cancer;Mangioni, C.; Bolis, G.; Valerne, I.; Moline, P.; Cis-diammine-dichloroplatinum, Sessa C.; Adriamycin;Proceedings of the American Association for Cancer Research,1981

4. Phase II study of cis-dichlorodiammine platinum (11) (NSC-119875) in advanced adenocarcinoma of the ovary;Wiltshaw, E.; Kroner, T.;Cancer Treat Rep,1976

5. Cis-dichlorodiammine platinum (11) for the treatment of advanced ovarian cancer;You-ng, R.C.; Von Hoff, D.B.; Gormley, P.;Canicer Treat Rep,1979

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High cost of chemotherapy for gynecologic malignancies;Japanese Journal of Clinical Oncology;2024-07-18

2. Heterogeneity and treatment landscape of ovarian carcinoma;Nature Reviews Clinical Oncology;2023-10-02

3. Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends;Indian Journal of Medical and Paediatric Oncology;2022-09-29

4. Current trends in chemotherapy for advanced ovarian cancer;Japanese Journal of Clinical Oncology;2022-05-04

5. Systemic treatment of newly diagnosed advanced epithelial ovarian cancer: From chemotherapy to precision medicine;Critical Reviews in Oncology/Hematology;2021-02